Drugplain

Hysingla ER 20 mg/1

hydrocodone bitartrate · TABLET, EXTENDED RELEASE · Knoa Pharma LLC

No Recall HistoryCurrently in Shortage
Plain English

Hysingla ER is a tablet, extended release containing hydrocodone bitartrate at 20 mg/1, taken oral. Manufactured by Knoa Pharma LLC.

Key Facts

Brand Name
Hysingla ER
Generic Name
hydrocodone bitartrate
NDC Code (Product)
59011-271
Manufacturer
Knoa Pharma LLC
Strength
20 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
NDA206627
Marketing Start
01/15/2015

Recall History

No Recall History

Frequently Asked Questions

What is Hysingla ER used for?

Hysingla ER contains hydrocodone bitartrate. It is a tablet, extended release taken oral. Consult your doctor for specific uses.

Is Hysingla ER a controlled substance?

Yes, Hysingla ER is classified as CII under the DEA Controlled Substances Act.

What is the generic name for Hysingla ER?

The generic name for Hysingla ER is hydrocodone bitartrate. There are 12 other brand versions of hydrocodone bitartrate.

What is the NDC code for Hysingla ER 20 mg/1?

The NDC (National Drug Code) for Hysingla ER 20 mg/1 is 59011-271, listed by Knoa Pharma LLC.